Table 2. Characteristics and main results of the studies included in this review.
| First author & year | Groups assessed | Pulmonary function (% of predicted) | Exercise testing used | Results of the exercise testing (% of predicted) | Conclusion of the exercise capacity |
|---|---|---|---|---|---|
| Frohlich et al. (2014) 22 | Healthy |
|
CPET | VO2max.: 101±17 | Reduced exercise capacity compared to healthy individuals (p-value<0.05) |
| PIBO |
|
VO2max.: 84±15 | |||
| Zenteno et al. (2009) 23 | PIBO |
|
6MWT | Distance covered: 598±71# | Preserved exercise capacity (>476 m) |
| Mattiello et al. (2008) 11 | PIBO |
|
|
|
Reduced exercise capacity (<80% of predicted) |
| Gerbase et al. (2008) 24 | PIBO | FEV1: 73.9±25.1 | 6MWT | Distance covered: 30.4 (4.5-8.1)* | Reduced exercise capacity (<80% of predicted) |
%: percentage; PIBO: post-infectious bronchiolitis obliterans; FEV1: forced expiratory volume in 1 second; FVC: forced vital capacity; FEV1/FVC: Tiffeneau index; FEF25-75: forced expiratory flow; CPET: cardiopulmonary exercise testing; 6MWT: six-minute walk test; VO2max.: maximal oxygen uptake; *data expressed in median and variation; #data presented in meters.